↓ Skip to main content

Dove Medical Press

Management of extrapulmonary sarcoidosis: challenges and solutions

Overview of attention for article published in Therapeutics and Clinical Risk Management, November 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
12 X users

Citations

dimensions_citation
67 Dimensions

Readers on

mendeley
103 Mendeley
Title
Management of extrapulmonary sarcoidosis: challenges and solutions
Published in
Therapeutics and Clinical Risk Management, November 2016
DOI 10.2147/tcrm.s74476
Pubmed ID
Authors

Khalid Al-Kofahi, Peter Korsten, Christian Ascoli, Shanti Virupannavar, Mehdi Mirsaeidi, Ian Chang, Naim Qaqish, Lesley A Saketkoo, Robert P Baughman, Nadera J Sweiss

Abstract

Sarcoidosis is a chronic multisystem disease of unknown etiology characterized by noncaseating granulomas that most often involves the lungs, but frequently has extrapulmonary manifestations, which might be difficult to treat in individual patients. To review different disease manifestations, focusing on extrapulmonary organ systems, and to provide treatment options for refractory cases. We performed a literature search using Medline and Google Scholar for individual or combined keywords of "sarcoidosis, extrapulmonary, treatment, kidney, neurosarcoidosis, cardiovascular, gastrointestinal, transplantation, musculoskeletal, rheumatology, arthritis, and skin". Peer-reviewed articles, including review articles, clinical trials, observational trials, and case reports that were published in English were included. References from retrieved articles were also manually searched for relevant articles. Isolated involvement of a single organ or organ system is rare in sarcoidosis, and thus all patients must be thoroughly evaluated for additional disease manifestations. Cardiac sarcoidosis and neurosarcoidosis may be life-threatening. Clinicians need to assess patients comprehensively using clinical, laboratory, imaging, and histopathological data to recommend competently the best and least toxic treatment option for the individual patient.

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 103 100%

Demographic breakdown

Readers by professional status Count As %
Other 12 12%
Researcher 10 10%
Student > Master 10 10%
Student > Bachelor 10 10%
Student > Postgraduate 8 8%
Other 19 18%
Unknown 34 33%
Readers by discipline Count As %
Medicine and Dentistry 56 54%
Nursing and Health Professions 3 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 <1%
Biochemistry, Genetics and Molecular Biology 1 <1%
Computer Science 1 <1%
Other 3 3%
Unknown 38 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2024.
All research outputs
#5,474,105
of 25,468,708 outputs
Outputs from Therapeutics and Clinical Risk Management
#277
of 1,324 outputs
Outputs of similar age
#83,004
of 318,007 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 24 outputs
Altmetric has tracked 25,468,708 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,324 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 318,007 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.